IBTROZI

Serial Number 98258541
Registration 8033646
700

Registration Progress

Application Filed
Nov 7, 2023
Under Examination
Sep 24, 2024
Approved for Publication
Jul 30, 2024
Published for Opposition
Jul 30, 2024
Registered
Nov 18, 2025

Trademark Image

IBTROZI

Basic Information

Serial Number
98258541
Registration Number
8033646
Filing Date
November 7, 2023
Registration Date
November 18, 2025
Published for Opposition
July 30, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 18, 2025
Registration
Registered
Classes
005

Rights Holder

NUVATION BIO INC.

03
Address
1500 BROADWAY, SUITE 1401
NEW YORK, NY 10036

Ownership History

AnHeart Therapeutics Inc.

Original Applicant
03
New York, NY

AnHeart Therapeutics Inc.

Owner at Publication
03
New York, NY

ANHEART THERAPEUTICS LLC

New Owner After Publication #1
16
NEW YORK, NY

NUVATION BIO INC.

New Owner After Publication #2
03
NEW YORK, NY

NUVATION BIO INC.

Original Registrant
03
NEW YORK, NY

Legal Representation

Attorney
Jenifer deWolf Paine

USPTO Deadlines

Next Deadline
2136 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20251118)
Due Date
November 18, 2031
Grace Period Ends
May 18, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

25 events
Date Code Type Description Documents
Nov 18, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 18, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 29, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 29, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 23, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 22, 2025 IUAF S USE AMENDMENT FILED Loading...
Sep 22, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jul 12, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 11, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 20, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 11, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 21, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 19, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Nov 20, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 24, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 30, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 30, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 10, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 23, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 15, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 11, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 11, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 11, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 5, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 10, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer
First Use Anywhere: Jun 13, 2025
First Use in Commerce: Jun 13, 2025

Classification

International Classes
005